| Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens SL Jongbloed, AJ Kassianos, KJ McDonald, GJ Clark, X Ju, CE Angel, ... Journal of Experimental Medicine 207 (6), 1247-1260, 2010 | 1198 | 2010 |
| A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer F Matin, V Jeet, L Moya, LA Selth, S Chambers, ... Scientific reports 8 (1), 6653, 2018 | 81 | 2018 |
| Emergence of microRNAs as key players in cancer cell metabolism S Subramaniam, V Jeet, JA Clements, JH Gunter, J Batra Clinical chemistry 65 (9), 1090-1101, 2019 | 69 | 2019 |
| Differential uptake and cross‐presentation of soluble and necrotic cell antigen by human DC subsets MC Chiang, KM Tullett, YS Lee, A Idris, Y Ding, KJ McDonald, ... European journal of immunology 46 (2), 329-339, 2016 | 68 | 2016 |
| Modeling prostate cancer: a perspective on transgenic mouse models V Jeet, PJ Russell, A Khatri Cancer and Metastasis Reviews 29, 123-142, 2010 | 63 | 2010 |
| MicroRNA theranostics in prostate cancer precision medicine F Matin, V Jeet, JA Clements, GM Yousef, J Batra Clinical chemistry 62 (10), 1318-1333, 2016 | 58 | 2016 |
| MicroRNAs in HPV associated cancers: small players with big consequences S Satapathy, J Batra, V Jeet, EW Thompson, C Punyadeera Expert review of molecular diagnostics 17 (7), 711-722, 2017 | 38 | 2017 |
| Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells V Jeet, G Tevz, M Lehman, B Hollier, C Nelson Endocrine-Related Cancer 21 (5), 723-737, 2014 | 32 | 2014 |
| Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway M Moniruzzaman, R Wang, V Jeet, MA McGuckin, SZ Hasnain International journal of molecular sciences 20 (14), 3468, 2019 | 28 | 2019 |
| Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer G Tevz, S McGrath, R Demeter, V Magrini, V Jeet, A Rockstroh, ... Molecular and Cellular Endocrinology 420, 159-168, 2016 | 24 | 2016 |
| Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1) MC Yeh, BWC Tse, NL Fletcher, ZH Houston, M Lund, M Volpert, ... EJNMMI research 10, 1-13, 2020 | 17 | 2020 |
| Cost-effectiveness analysis of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) for the primary staging of prostate cancer in … R Song, V Jeet, R Sharma, M Hoyle, B Parkinson Pharmacoeconomics 40 (8), 807-821, 2022 | 15 | 2022 |
| Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer V Jeet, K Ow, E Doherty, B Curley, PJ Russell, A Khatri The Prostate 68 (5), 548-562, 2008 | 15 | 2008 |
| MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members including prostate-specific antigen in prostate cancer F Matin, V Jeet, S Srinivasan, AS Cristino, J Panchadsaram, JA Clements, ... Clinical chemistry 65 (6), 771-780, 2019 | 14 | 2019 |
| Allele-specific microRNA-mediated regulation of a glycolysis gatekeeper PDK1 in cancer metabolism S Subramaniam, V Jeet, JH Gunter, JA Clements, J Batra Cancers 13 (14), 3582, 2021 | 10 | 2021 |
| Targeting aurora kinases: a novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer V Jeet, P J Russell, N D Verma, A Khatri Current Cancer Drug Targets 12 (2), 144-163, 2012 | 10 | 2012 |
| Patient preferences in targeted pharmacotherapy for cancers: a systematic review of discrete choice experiments S Jiang, R Ren, Y Gu, V Jeet, P Liu, S Li Pharmacoeconomics 41 (1), 43-57, 2023 | 9 | 2023 |
| Histopathologically validated diagnostic accuracy of PSMA-PET/CT in the primary and secondary staging of prostate cancer and the impact of PSMA-PET/CT on clinical management: a … V Jeet, B Parkinson, R Song, R Sharma, M Hoyle Seminars in Nuclear Medicine, 2023 | 7 | 2023 |
| Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic review A Ahumada-Canale, V Jeet, A Bilgrami, E Seil, Y Gu, H Cutler Social Science & Medicine 322, 115790, 2023 | 3 | 2023 |
| Using Australian panel data to account for unobserved factors in measuring inequities for different channels of healthcare utilization J Fooken, V Jeet The European Journal of Health Economics 23 (4), 717-728, 2022 | 1 | 2022 |
